View Older Stories View More Recent Stories
-
Roth Capital Upgrades Glu Mobile (GLUU) to Buy
-
Interpace Diagnostics (IDXG) Prices 1.2M Shares at $3
-
Interpace Diagnostics Announces Pricing of Public Offering to Raise $3.6 Million
-
RGS Energy (RGSE) Prices $11.5M Offering of Common Stock and Warrants
-
RGS Energy Prices $11.5 Million Public Offering of Common Stock and Warrants
-
Roth Capital Upgrades xG Technology, Inc. (XGTI) to Buy
-
Enphase Energy (ENPH) PT Raised to $1.50 at Roth Capital
-
Roth Capital Downgrades Acuity Brands (AYI) to Sell on Mexican Tariff Risk
-
Horizon Global (HZN) Prices 4M Share Offering at $18.50, $110M in Convertible Senior Note
-
Horizon Global Announces Pricing of Offerings of Common Stock and Convertible Senior Notes
-
RGS Energy Announces Public Offering of Common Stock and Warrants
-
Roth Capital Starts Spartan Motors (SPAR) at Buy
-
Roth Capital Starts Tetra Tech (TTEK) at Buy
-
Intrexon (XON) to Acquire GenVec (GNVC)
-
Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform
-
Roth Capital Upgrades American Vanguard Corp. (AVD) to Buy
-
Stemline Therapeutics (STML) Prices 4.5M Shares at $10
-
Stemline Therapeutics Prices $45 Million Public Offering of Common Stock
-
Zynerba Pharma (ZYNE) Prices 2.8M Shares at $18 Per Share
-
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Roth Capital Downgrades Ideal Power (IPWR) to Neutral
-
Roth Capital Downgrades Alcobra Ltd. (ADHD) to Neutral
-
Roth Capital Downgrades Derma Sciences (DSCI) to Neutral
-
PlacementTracker Publishes 2016 Private Placement Market League Tables
-
Roth Capital Starts TPI Composites (TPIC) at Buy
-
PIPE Deals Positioned to Soar in 2017 with Trump Deregulation Gift
-
Pre-Open Stock Movers 01/11: (BIOC) (DSCI) (ENPH) Higher; (NVDQ) (ETH) (SIG) Lower (more...)
-
Roth Capital Downgrades Himax Technologies (HIMX) to Neutral
-
Roth Capital Starts Polar Power (POLA) at Buy
-
Mast Therapeutics (MSTX) to Merge with Savara
-
Mast Therapeutics And Savara Sign Merger Agreement
-
ROTH Capital Partners appoints Michael Margolis, R.Ph. as Head of Healthcare Investment Banking
-
MaxLinear, Inc. to Present at Upcoming Financial Conferences
-
Pre-Open Stock Movers 01/04: (EVOK) (CBAY) (OCUL) Higher; (AGRX) (ACUR) (ENSG) Lower (more...)
-
Roth Capital Starts Kite Pharma (KITE) at Buy
-
Roth Capital Starts Paramount Gold and Silver (PZG) at Buy
-
After-Hours Stock Movers 01/03: (CBAY) (SHAK) (CC) Higher; (AGRX) (ACUR) (TSLA) Lower (more...)
-
Acura Pharma (ACUR) Exploring Strategic Options, Including Possible Sale
-
Acura Pharmaceuticals Exploring Strategic Alternatives
-
RedHill Biopharma Announces Exercise of Underwriters' Option
-
RedHill Biopharma Announces Exercise of Underwriters’ Option
-
Roth Capital Starts SenesTech (SNES) at Buy
-
Roth Capital Starts Ameresco (AMRC) at Neutral
-
RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters
-
RedHill Biopharma Announces Closing of Concurrent Public Offering and Registered Direct Offering of its American Depositary Shares and Warrants and Partial Exercise of the Option of Underwriters
-
NeuroDerm Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Roth Capital Starts LightPath Technologies (LPTH) at Buy
-
LightPath Technologies Completes Acquisition of ISP Optics Corporation
-
Roth Capital Downgrades InvenSense (INVN) to Neutral
-
RedHill Biopharma (RDHL) Prices Common Stock, Warrant Offering

